Skip to main content

Table 1 Patient characteristics (n = 515)

From: The impact of severe haemophilia and the presence of target joints on health-related quality-of-life

Age (mean ± SD) 37.7 ± 15.0
Age categories (%)
 18–30 205 (39.8%)
 31–40 119 (62.9%)
 41–50 89 (17.3%)
 51–60 50 (9.7%)
 61 + 52 (10.1%)
Subtype (%)
 Haemophilia A 400 (77.7%)
 Haemophilia B 115 (22.3%)
Country (%)
 France 180 (35.0%)
 Germany 96 (18.6%)
 Italy 118 (22.9%)
 Spain 84 (16.3%)
 UK 37 (7.2%)
Treatment Strategy (%)
 On-demand 201 (39.0%)
 Primary prophylaxis 314 (61.0%)
Physician-reported comorbidities
 Depression 77 (15.0%)
 Anxiety 84 (16.5%)
Target joints (total) 714
Target joints (mean ± SD (range)) 1.39 ± 1.44 (0–9)
Number of target joints (patient n, %)
 Zero 157 (30.5%)
 One 153 (29.7%)
 Two 130 (25.2%)
 Three or more 75 (14.6%)
Location of target joints (patient n, %)
 Exclusively upper body 92 (25.7%)
 Exclusively lower body 188 (52.5%)
 Upper and lower body 78 (21.8%)
  1. Note. Values are means ± SD or numbers (%)